| |
| |
|
| Insider
Information: |
Dube Eric M |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
350,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,398,104 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
350,600 |
|
|
| Total
Value |
$2,398,104 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Travere Therapeutics, Inc |
TVTX |
|
2024-02-01 |
350,600 |
2019-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2019-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
77,500 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
105,500 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
57,260 |
145,079 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
160,079 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
166,439 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
164,751 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
37,848 |
169,558 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
97,500 |
245,346 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2023-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,900 |
247,050 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
369,722 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-01 |
4 |
AS |
$8.53 |
$166,435 |
D/D |
(19,122) |
350,600 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-23 |
4 |
AS |
$8.96 |
$70,542 |
D/D |
(7,873) |
234,722 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2020-01-07 |
4 |
AS |
$13.94 |
$52,275 |
D/D |
(3,750) |
46,250 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-06-02 |
4 |
AS |
$14.35 |
$68,593 |
D/D |
(4,780) |
147,251 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2023-09-05 |
4 |
AS |
$14.71 |
$65,533 |
D/D |
(4,455) |
242,595 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-06-01 |
4 |
AS |
$14.89 |
$71,204 |
D/D |
(4,782) |
152,031 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2020-01-08 |
4 |
AS |
$15.14 |
$56,775 |
D/D |
(3,750) |
42,500 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-08-17 |
4 |
S |
$17.12 |
$134,142 |
D/D |
(7,836) |
156,915 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2020-09-21 |
4 |
S |
$19.28 |
$208,319 |
D/D |
(10,805) |
94,695 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2023-01-24 |
4 |
AS |
$21.50 |
$138,503 |
D/D |
(6,442) |
147,846 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2023-02-01 |
4 |
AS |
$22.25 |
$182,361 |
D/D |
(8,196) |
237,150 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2022-01-24 |
4 |
AS |
$24.98 |
$196,668 |
D/D |
(7,873) |
131,710 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-01-05 |
4 |
AS |
$26.65 |
$91,623 |
D/D |
(3,438) |
91,257 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2021-01-06 |
4 |
AS |
$27.01 |
$92,860 |
D/D |
(3,438) |
87,819 |
0 |
% |
|
33 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
